Method Article

Imaging and Quantification of Immune Cells in the Tumor Microenvironment Using a Zebrafish Model of Neuroblastoma

13 views

DOI:

10.3791/72028

September 18th, 2026

 ,  ,  ,  ,  , 

Corresponding Authors: Hui Feng <huifeng@bu.edu>

* These authors contributed equally

In This Article

Summary

This protocol describes methods for generating compound transgenic zebrafish, imaging immune cells associated with tumors in larval and adult zebrafish, and quantifying immune cell frequency within the tumor microenvironment.

Abstract

The recruitment of immune cells to the tumor microenvironment (TME) is an important component of immune regulation and tumor progression. Studying the spatial and temporal relationships between immune and tumor cells in vivo can provide insight into interactions within the TME. However, visualizing and quantifying these interactions in intact organisms remains challenging using conventional imaging and histological approaches. Zebrafish provide a valuable model for cancer research owing to their genetic tractability, rapid development, and optical transparency during early developmental stages, enabling visualization of fluorescently labeled cells in vivo. Here, we present a protocol to generate, identify, image, and quantify immune and tumor cells that are differentially labeled with fluorescent markers in a zebrafish model of neuroblastoma. The protocol includes breeding and screening of compound transgenic zebrafish, live imaging of larvae, preparation and imaging of adult tumor-bearing fish, and quantification of immune cells surrounding and within tumor regions. Using transgenic reporter lines, CD4+ immune cells and MYCN-driven neuroblastoma cells can be visualized and analyzed at different developmental stages. The workflow enables assessment of immune cell localization relative to tumors in both larval and adult fish and can be used to compare immune cell abundance across disease stages. This protocol provides a reproducible approach for imaging and quantifying immune cells within the TME in vivo using zebrafish and may facilitate studies of immune–tumor interactions in other cancer models.

Introduction

The tumor microenvironment (TME) is an ecosystem composed of tumor, immune, fibroblast, and vascular cells1. The TME plays an essential role in cancer progression, therapeutic response, and anti-tumor immunity. Within the TME, immune cells are key regulators of tumor fate, either participating in anti-tumor responses or inducing immunosuppression2. Understanding the recruitment, distribution, and function of immune cells within the TME is critical for elucidating the mechanisms by which tumors evade immune surveillance. However, conventional approaches to studying the TME, such as endpoint histology, flow cytometry, and single-cell sequencing, provide only static snapshots and often require disruption of tissue structure, resulting in the loss of spatial information and cell-cell interactions3,4,5,6,7. Moreover, these methods are limited in their ability to visualize and quantify immune cells within the TME, especially during the early stages of tumor development.

Zebrafish (Danio rerio) are a powerful model for cancer research due to their low cost, rapid development, relative transparency, and high genetic conservation8,9. These advantages provide a reproducible and scalable experimental system that allows large sample sizes and efficient microscopy screening within a short time frame10. Importantly, zebrafish share significant immunological conservation with humans, including key components of both innate and adaptive immune systems, making findings relevant to human disease11. These properties are particularly useful for studying pediatric cancers such as neuroblastoma8. Consequently, numerous zebrafish immune-reporter lines and cancer models have been developed11. Therefore, zebrafish serve as a valuable in vivo model for studying interactions between tumor and immune cells, offering insight into how immune regulation shapes tumor development, particularly during early stages.

Previous studies investigating the TME in zebrafish have heavily relied on tumor xenograft models combined with endpoint imaging to assess immune cell localization within tumors12,13,14,15,16,17. While these methods provide useful insights, they are limited by their reliance on two-dimensional imaging, which cannot fully capture the three-dimensional organization of the TME and the spatial relationships between tumor and immune cells during development14. In addition, tumor xenograft models involve the artificial transplantation of human tumor cells and may not fully recapitulate natural tumor initiation18. These models are also typically short-term and cannot fully capture tumor progression or changes in the spatial relationship between tumor and immune cells during development14,19. Furthermore, this approach provides a limited representation of the spatial organization, developmental context, and physiological relevance of immune cell behavior within the TME. Recently, we and others have applied compound transgenic zebrafish, in which tumor and immune cells are differentially labeled with fluorescent markers, to visualize immune cells associated with tumors20,21. These compound transgenic fish enable the study of the TME throughout animal and tumor development, facilitating investigations of immune-tumor interactions in vivo.

Here, we present a method that utilizes confocal microscopy to study immune cells within the TME of a zebrafish neuroblastoma model. In this approach, we used zebrafish reporter lines that label immune cells and a genetically engineered zebrafish line that overexpresses the human MYCN oncogene under the dopamine-β-hydroxylase promoter (dβh), resulting in the development of neuroblastoma resembling human disease20. In this compound transgenic zebrafish model, tumor and immune cells are differentially labeled with EGFP and mCherry, respectively. The dβh promoter is active in sympathoadrenal lineage cells and has been used in multiple zebrafish models of neuroblastoma22,23,24,25. Additionally, we utilized a Cd4 promoter driving mCherry fluorescence to visualize CD4+ cells15. Confocal imaging with Z-stack acquisition was applied to visualize the TME in three dimensions at different stages of tumor development, enabling assessment of the spatial relationships between tumor and immune cells within intact tissue. This method enables analysis of the organization of immune cells relative to tumor cells during different stages of tumor development.

Protocol

All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at Boston University Chobanian & Avedisian School of Medicine under protocol PROTO202100001. The overall workflow for generation of compound transgenic zebrafish, larval imaging, adult tissue preparation, and image analysis is summarized in Figure 1.

figure-protocol-1
Figure 1. Workflow for visualization and quantification of immune cells within the zebrafish tumor microenvironment (TME). Schematic overview of the experimental workflow. Immune-reporter zebrafish were crossed with tumor-prone zebrafish to generate compound transgenic offspring expressing fluorescent markers in both immune cells (red) and tumor cells (green). Embryos were screened by fluorescence microscopy to identify compound transgenic fish. Selected fish were either subjected to live confocal imaging during larval development (<21 days post-fertilization [dpf]) or processed by fixation, cryosectioning, and confocal imaging for fish older than 21 dpf. This workflow enables visualization and quantification of immune cells associated with the TME across multiple developmental stages. Part of the illustration was created using BioRender. Please click here to view a larger version of this figure.

1. Generation of Compound Transgenic Zebrafish Lines Through Breeding

  1. Select adult immune-reporter fish and tumor fish that are at least 3 months old for natural breeding.
    NOTE: For the representative results, Tg(cd4-1:mCherry) heterozygous fish were crossed with Tg(dβh:MYCN; dβh:EGFP) heterozygous fish to differentially label immune cells and tumor cells15,23.
  2. On the evening before breeding, fill a two-chamber mating tank two-thirds full with fish water.
  3. Place a grated top insert into the mating chamber. Use dividers to separate one male from one or two females.
  4. Leave the dividers in place overnight. Add artificial plants or other enrichment items to simulate natural breeding conditions.
    NOTE: A 1:2 male-to-female ratio increases the likelihood of successful spawning when breeding tumor male fish with immune-reporter fish. Do not breed two males with one female, as competition between males may occur.
  5. On the following morning, remove the dividers after the facility lights turn on.
  6. Tilt the grated top chamber slightly using the divider as a wedge to create a shallow water area. Allow the fish to spawn for at least 1 h.
  7. Collect eggs from the bottom of the mating chamber by pouring the water through a fine-mesh net.
  8. Transfer the eggs to a sterile Petri dish containing fish water at a density no greater than 1 egg per 50 mm2 (approximately 200 eggs per 100 mm dish).
  9. Remove dead and unfertilized eggs.
    NOTE: Healthy fertilized eggs are translucent and round. Remove cloudy, white, unfertilized, or deformed eggs.
  10. Double-check the fish to avoid mixing sexes or cross-contaminating transgenic tanks.
  11. Return the males and females to their respective tanks.
  12. Place the embryos in a 28.5°C incubator overnight. Do not exceed the embryo density specified in Step 1.8.
  13. Bleach the embryos on the following morning to remove contaminants.
    1. Prepare a working bleach solution consisting of 100 µL bleach in 200 mL system water. Prepare a neutralization solution consisting of 0.5 g sodium thiosulfate in 150–200 mL system water.
    2. Sort and transfer viable embryos into a mesh-net well insert. Submerge the insert in the bleach solution for 5 min.
    3. Transfer the insert directly into the sodium thiosulfate solution. Incubate for 2 min to neutralize residual bleach.
    4. Rinse the embryos in a final bath of fresh system water. Use a squirt bottle to gently transfer the embryos into clean petri dishes containing fresh system water.
  14. Return the embryos to the incubator after bleaching.
  15. Transfer larvae at 5–7 days post-fertilization (dpf) or later to a larger tank containing 5 ppt rotifer water for rearing.
    1. Prepare 5 ppt rotifer water by mixing 1 part stock rotifer water (15 ppt) with 2 parts zebrafish system water.
    2. Verify that the final salinity is 5 ppt using a conductivity meter before transferring the larvae.
      NOTE: Sorting EGFP+ MYCN larvae at 3–5 dpf facilitates identification of tumor-prone fish before rearing. Sorting MYCN embryos at this stage avoids false-negative identification because EGFP expression in neural crest cells may decrease later in development due to MYCN-induced apoptosis.

2. Screening Zebrafish for Fluorescent Markers

  1. Prepare a 0.4% (w/v) tricaine stock solution using system water.
  2. Transfer the fish to a clean petri dish containing only enough system water to cover the bottom.
  3. Add the tricaine stock solution to achieve a final concentration of approximately 0.005% (50 mg/L) for fish younger than 14 dpf or 0.012% (120 mg/L) for fish older than 14 dpf. Confirm adequate anesthesia by observing little to no voluntary movement.
  4. Remove excess water from the dish once the fish are anesthetized and no longer capable of swimming while maintaining visible opercular or cardiac movement.
  5. Screen the fish for fluorescence. Identify green or red fluorescence in the expected region (e.g., the interrenal gland region in MYCN fish).
  6. Separate the fish into groups using a stiff-bristled sorting tool.
    NOTE: Sort tumor-prone fish as early as possible because MYCN-induced apoptosis during later developmental stages may result in false-negative identification. Sort immune-reporter fish immediately before imaging at the larval stage or between 2 and 4 months of age for adult studies. This approach minimizes handling-associated stress and maximizes survival.
  7. Transfer positive and negative fish to separate tanks containing system water for continued rearing.
    NOTE: Step 3 describes handling and imaging of larvae younger than 21 dpf. Steps 4–6 describe fixation, tissue preparation, imaging, and image analysis of older fish.

3. Larval Live-Mounting and Imaging

  1. Place sorted larvae in a 100 mm petri dish containing tricaine fish water (see Step 2.3 for age-appropriate concentrations).
  2. Transfer the sedated larvae to a glass-bottom imaging dish.
  3. Use only enough solution to cover the larva and maintain sedation.
  4. Prepare 1%–1.5% low-melting agarose in fish water. Heat the agarose solution until fully dissolved.
  5. Allow the agarose to cool for 1–2 min. Maintain the agarose at 30°C using a heat block to prevent solidification prior to mounting.
  6. Position each larva laterally in the imaging dish.
  7. Apply approximately 30–200 µL of agarose over the larva to immobilize it. Use larger volumes for larger larvae and smaller volumes for smaller larvae.
  8. Once the agarose has solidified, add approximately 100 µL of 0.005% tricaine solution over the agarose.
  9. Image the larvae using a confocal microscope.
    1. Use a standard laser-scanning confocal microscope with a resonant scanner. Use a 40× objective with a numerical aperture greater than 1.10.
    2. Set the pinhole to 1.0 Airy unit (AU) for all imaging channels.
    3. Use a 488 nm laser for EGFP excitation and a 594 nm laser for mCherry excitation. Keep laser output below 25 mW to minimize photobleaching and phototoxicity. Adjust detector gain and laser power using a range indicator lookup table (LUT) to avoid pixel saturation and black clipping. Do not exceed a detector gain of 800 V because higher voltages introduce excessive noise.
    4. Use a voxel size of 0.42 × 0.42 × 6.0 µm (x, y, z) at a resolution of 1024 × 1024 pixels and a Z-step interval of 6.0 µm. Acquire optical sections continuously through the full volume of interest, typically spanning 90–120 µm in total imaging depth. Use highly sensitive photodetectors operating in 16-bit acquisition mode.
    5. Acquire images using unidirectional line scanning at a resonant scan frequency of 33.3 kHz (approximately 1.58 µs pixel dwell time). Use 2× or 4× averaging to reduce motion artifacts while limiting laser exposure.
      NOTE: Optimize tricaine exposure to maintain larval survival during imaging. After imaging, add fish water until the imaging dish is approximately half full.
  10. Add fresh fish water to the imaging dish immediately after imaging.
  11. Gently remove the larva from the agarose using a stiff-bristled stick and transfer the larva to a dish containing clean fish water for recovery.
  12. Return the fish to its original tank once normal swimming behavior resumes.
    NOTE: For fish older than 21 dpf, the skin overlying the tumor must be removed by cryosectioning to enable high-resolution confocal imaging.

4. Fish Fixation and Cryosectioning

  1. Euthanize fish in accordance with approved institutional animal care guidelines.
  2. Make a ventral incision extending from the anal pore to the pectoral girdle to expose the abdominal cavity and facilitate fixative penetration into internal tissues.
  3. Transfer the fish using forceps into a 1.5 mL tube containing 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) or a volume of fixative at least 10-fold greater than the tissue volume.
    NOTE: Avoid handling the region containing the tumor to preserve tissue integrity.
  4. Place the samples on a nutating rocker set to gentle continuous agitation (30 rpm) and incubate overnight for at least 12 h at 4°C.
    CAUTION: PFA is hazardous, toxic, and potentially carcinogenic. Wear appropriate personal protective equipment, including gloves and eye protection. Perform all procedures involving PFA in a fume hood and avoid inhalation of vapors.
  5. Remove the PFA and wash the samples at least four times with 1.5 mL of 1× PBS. Gently invert the tube two to three times during each wash.
  6. Transfer the fish to 30% sucrose prepared in PBS.
  7. Incubate the fish in a cold room overnight until the specimen sinks to the bottom of an upright tube (approximately 12 h), indicating adequate sucrose penetration.
  8. Remove excess sucrose solution by gently blotting the fish on a laboratory tissue.
  9. Transfer the fish to storage tubes.
  10. Store the samples at −80°C until imaging.
    NOTE: Process samples within 3 months to minimize fluorescent protein degradation and signal loss.
  11. Transport the fixed fish to the cryostat room on dry ice.
  12. Place the fish flat in a plastic mold with one sagittal side facing downward.
  13. Add Optimal Cutting Temperature (OCT) compound until the fish is fully covered.
  14. Freeze the mold at −20°C or in the cryostat until the OCT turns white.
    NOTE: Position the fish as flat as possible before freezing to facilitate consistent sectioning.
  15. Cryosection the zebrafish in the sagittal plane to remove the skin for subsequent whole-mount imaging.
    1. Cool the cryostat chuck.
    2. Apply room-temperature OCT to the chuck.
    3. Press the OCT fish block firmly into the OCT layer.
    4. Freeze the chuck and block until the newly applied OCT turns white.
    5. Mount the chuck in the cryostat.
    6. Cryosection the block at a thickness of 14 µm until the blade reaches the specimen.
      NOTE: Specimen shifting may occur during freezing, causing the fish to sit higher in the block than expected. Entry into the specimen is indicated by the appearance of translucent tissue replacing the opaque OCT background.
    7. Reduce the section thickness to 7 µm.
    8. Continue sectioning for one additional cut.
      NOTE: This procedure removes the skin while preserving a uniform sagittal profile across the specimen.
    9. Confirm the endpoint by identifying skin in the collected sections.
      ​NOTE: Skin appearance in sections provides a more reliable indicator than eye morphology. Perform this procedure only when the skin obscures imaging of the tumor microenvironment.
  16. Warm the chuck gently with your hands.
  17. Remove the OCT block from the chuck using forceps. Avoid disturbing the cut surface of the specimen.
  18. Trim excess OCT surrounding the fish while the OCT remains frozen.
  19. Remove the fish from the OCT block using forceps once the OCT softens to a viscous consistency.

5. Mounting and Imaging of Fish with Skin Removed

  1. Place the fish in a glass-bottom dish with the sectioned sagittal side facing the glass surface.
    NOTE: Maintain the orientation of the fish during handling. Identifying the sectioned side may become difficult after the fish is removed from the OCT block.
  2. Prepare 1%–1.5% low-melting agarose.
  3. Apply approximately 30–50 µL of agarose to the dorsal and ventral sides of the fish to secure the sample.
    NOTE: Avoid placing agarose beneath the fish because it can reduce image quality. Use only the minimum amount of agarose required for stabilization.
  4. Keep the sample on ice during transport. Image the sample within 2 h of mounting.
  5. Transport the sample to the confocal microscopy facility.
  6. Image the sample using confocal microscopy.
    1. Use a standard laser-scanning confocal microscope with a resonant scanner. A two-photon microscope may be used when autofluorescence limits image quality. Use a corrected 20× objective lens with a numerical aperture of at least 0.80.
    2. Set the pinhole to 1.0 Airy unit (AU) for all imaging channels.
    3. Use a 488 nm laser for EGFP excitation and a 594 nm laser for mCherry excitation. Keep laser output below 25 mW. Adjust detector gain and laser power using a range indicator lookup table (LUT) to avoid pixel saturation and black clipping. Do not exceed a detector gain of 800 V because higher voltages introduce excessive noise.
    4. Configure image acquisition parameters as follows.
      1. Use a voxel size of 0.42 × 0.42 × 6.0 µm (x, y, z) at a resolution of 1024 × 1024 pixels and a Z-step interval of 6.0 µm.
      2. Acquire spectral image stacks through the full volume of interest, typically spanning a total Z-stack acquisition range of 90–120 µm (15–20 optical sections).
      3. Initiate image acquisition in the fluid space immediately above the tissue surface and continue through the full target imaging depth to ensure complete coverage of the specimen.
      4. Acquire images using highly sensitive photodetectors operating in 16-bit acquisition mode.
    5. Acquire images using unidirectional line scanning at a resonant scan frequency of 33.3 kHz (approximately 1.58 µs pixel dwell time) with 8× line averaging.

6. Image Analysis and Quantification

  1. Image visualization using Fiji (version 1.54p).
    1. Open the confocal z-stack images.
    2. Merge colors to see channel overlay by selecting Image > Color > Merge Channels.
    3. Generate a projection of the full z-range containing the imaging region by selecting Image > Stacks > Z Project. Enter the slice range of interest, as well as Max Intensity projection type. This will display the 2D projection of the image.
      NOTE: For larval fish, it is feasible to capture the whole TME by confocal microscopy. Therefore, we recommend the volumetric normalization and quantification method for the TME analysis. For older fish, it is impossible to capture the whole TME by confocal microscopy; therefore, we recommend applying the area-based normalization and quantification method. Based on our analysis and quantification of the larval fish, both methods can provide reliable biological results.
  2. Volumetric normalization and quantification of the TME in the larval fish.
    1. Quantifying tumor volume using MATLAB R2022b (download the package from the Matlab website) and Bio-Formats package (download from the openmicroscopy website).
    2. The user runs a script that performs the following tasks:
      1. Prompt the user to select a .CZI file from their computer.
      2. Read the image and extract the data from the channel containing the tumor region.
      3. Identify the region for each slice that is the tumor region through a threshold of fluorescence (can be through user input or machine learning), keeping the same threshold for all analyzed images for consistency.
      4. Outline the tumor region and display the image with the tumor region outlined in a collage of all slices for user verification.
      5. Calculate the area of the tumor region per slice in pixels and convert to mm2 using the scale of the image and imaging settings.
      6. Multiply the area of the tumor region by the depth (stored in the file’s metadata) to get the volume of each slice.
      7. Sum the calculated values of each slice to obtain the total volume of the imaged tumor and its surrounding region in voxels or mm3.
      8. Scale both volume measurements by multiplying by 10for tumor volume and 10for the surrounding region. This will create a more reasonable cell number:volume ratio during normalization.
    3. Quantifying cell number.
      1. Open the confocal z-stack images.
      2. Merge colors to see channel overlay by selecting Image > Color > Merge Channels.
      3. Generate a 3D view of the full z-range containing the imaging region by selecting Image > Stacks > 3D Project. Select Brightest Point as the projection method and other settings to the desired values.
      4. Due to the small number of cells, manually count and tabulate the cells, separating cells located within the tumor boundary from those located outside the tumor boundary.
        NOTE: Cells on the boundary of the tumor region are counted as being outside.
    4. Normalization.
      1. For infiltrating cells inside the tumor region, divide the number of cells by the scaled tumor volume. For the cells outside the tumor region, divide the number of cells outside the tumor volume by the scaled volume of the full image minus the tumor volume.
      2. Generate a table that includes the following headings: “fish identification”, “tumor volume”, “# of cells inside tumor region”, “# of cells outside tumor region”, “normalized cells inside”, “normalized cells outside”.
  3. Area-based normalization and quantification of the TME.
    1. Define the tumor region of interest (ROI) using the Rectangle or Freehand selection tool to outline the tumor.
    2. Add the ROI to the ROI Manager by pressing T or by selecting Analyze > Tools > ROI Manager > Add.
    3. Measure the ROI area using Analyze > Measure.
    4. Confirm that Area is selected under Set Measurements before recording measurements.
    5. Save the ROI in the ROI Manager.
    6. Apply the same ROI to all images using ROI Manager > More > Multi-Measure.
    7. Do not resize the ROI between images.
    8. Manually count cells within the ROI. If cells are more, count cells using the Cell Counter plugin by selecting Plugins > Analyze > Cell Counter.
    9. Mark each counted cell by left-clicking when its centroid falls within the ROI.
    10. Scroll through the z-stack to verify cell identity.
    11. Avoid counting the same cell more than once across multiple image planes.
    12. Count infiltrating cells separately if they contact or lie within the tumor boundary.
    13. Record infiltrating cells as a distinct category even when the cell centroid falls outside the ROI.
    14. Convert the ROI area from pixels to mm2.
    15. Obtain the pixel width, pixel height, and Z-step interval from Image > Properties.
    16. Calculation of normalized cell counts.
      1. Divide the raw cell count for each fish by the corresponding ROI area value.
      2. Record the resulting value as the normalized cell count.
      3. For absolute density measurements, calculate the physical area using the image calibration values obtained from Image > Properties.
      4. Divide the raw cell count by the calculated area (mm2).
      5. Record the result as cell density expressed as cells/mm2.

Results

The overall experimental workflow is shown in Figure 1. Adult Tg(cd4-1:mCherry) zebrafish were crossed with Tg(dβh:MYCN;dβh:EGFP) zebrafish to generate compound transgenic offspring in which CD4+ cells and dβh-expressing cells were differentially labeled with mCherry and EGFP fluorescence, respectively. Embryos were screened for the appropriate fluorescent markers and subsequently analyzed by either live confocal imaging during larval development or confocal imaging following fixation and cryosectioning in older fish (Figure 1).

To assess the association of CD4+ cells with premalignant neuroblastoma lesions during larval development, compound transgenic fish were imaged at 7 and 14 days post-fertilization (dpf). The time points were selected based on stages of zebrafish lymphocyte development26,27. Representative confocal images are shown in Figure 2A. At 7 dpf, CD4+ cells were infrequently observed within or surrounding the dβh-expressing region in both control and MYCN-expressing fish (Figure 2A; Supplementary Videos 1 and 2). At 14 dpf, MYCN-expressing fish exhibited increased numbers of CD4+ cells associated with the neural crest-derived premalignant tumor compared with the neural crest-derived sympathoadrenal progenitor region in control fish (Figure 2A; Supplementary Videos 3 and 4).

To account for differences in tumor size and the ability of confocal microscopy to capture the whole tumor in the larval fish, we compared both volumetric and area-based normalization methods. Importantly, volumetric- and area-based normalization methods yielded comparable results in larval fish, supporting the use of area-based normalization for adult tumors when complete tumor volume cannot be captured by confocal microscopy. Quantification demonstrated no significant difference in the number of surrounding CD4+ cells between groups at either time point (Figure 2B, bottom; n = 4 and 6 at 7 dpf and n = 4 and 5 at 14 dpf for the control and MYCN groups, respectively). In contrast, MYCN-expressing fish exhibited significantly greater infiltration of CD4+ cells within the analyzed region at 14 dpf compared with control fish (Figure 2B, top; P < 0.05; n = 4 and 5 for the control and MYCN groups, respectively). Data are presented as normalized cell counts relative to tumor volume (cells/mm3) and expressed as mean ± SEM.

figure-results-1
Figure 2. Increased association of CD4+ cells with MYCN-expressing neuroblastoma lesions at 14 days post-fertilization. (A) Representative confocal images of Tg(dβh:EGFP;Cd4-1:mCherry) control fish and Tg(dβh:MYCN;dβh:EGFP;Cd4-1:mCherry) fish at 7 and 14 days post-fertilization (dpf). EGFP-positive cells (green) mark dβh-expressing neural crest-derived/neuroblastoma cells, and CD4+ cells are labeled with mCherry (red). Arrows indicate representative CD4+ cells associated with the neural crest/tumor region. Scale bars = 50 µm. (B) Quantification of CD4+ cells surrounding (bottom) and infiltrating (top) the neural crest/tumor region in control and MYCN-expressing fish at 7 and 14 dpf. Cell counts were normalized to tumor volume (cells/mm3). Data are presented as mean ± SEM. Statistical comparisons were performed using unpaired two-tailed t-tests. P < 0.05. n = 4 and 6 at 7 dpf and n = 4 and 5 at 14 dpf for the control and MYCN groups, respectively. Representative data from three independent experiments. Please click here to view a larger version of this figure.

To examine CD4+ cell association with established tumors, sorted compound transgenic fish were raised to adulthood and analyzed following fixation, cryosectioning, and confocal imaging (Figure 1). Representative images of localized and metastatic neuroblastoma from 4-month-old fish are shown in Figure 3A. Tumors were classified as metastatic when EGFP-positive tumor cells were detected outside the peripheral sympathetic ganglia. We applied an area-based quantification method because confocal microscopy cannot capture the entire tumor volume. Our analysis revealed significantly increased numbers of CD4+ cells surrounding or infiltrating metastatic tumors compared with localized tumors (Figure 3B; P < 0.05; n = 4 per group). Data are presented as normalized cell counts per tumor area (cells/mm2) and expressed as mean ± SEM.

figure-results-2
Figure 3. Metastatic neuroblastoma exhibits increased CD4+ cell infiltration within the tumor microenvironment. (A) Representative confocal images of localized and metastatic neuroblastoma arising in 4-month-old sibling Tg(dβh:MYCN;dβh:EGFP;Cd4-1:mCherry) zebrafish. Tumor cells are labeled with EGFP (green), and CD4+ cells are labeled with mCherry (red). Arrows indicate representative CD4+ cells associated with tumor tissue. Images acquired using 20× and 63× objectives are shown as independent fields of view. Scale bars = 100 µm (20×) and 50 µm (63×). (B) Quantification of total CD4+ cells surrounding or infiltrating localized and metastatic tumors. Cell counts were normalized to tumor size as described in the protocol. Data are presented as mean ± SEM. Statistical comparisons were performed using unpaired two-tailed t-tests. P < 0.05. n = 4 per group. Representative data from three independent experiments. Please click here to view a larger version of this figure.

These findings demonstrate that the protocol can be used to visualize and quantify CD4+ cells associated with neuroblastoma lesions at multiple stages of tumor development in zebrafish.

Supplementary Video 1. Representative confocal z-stack of a control zebrafish at 7 days post-fertilization. Three-dimensional confocal imaging of a Tg(dβh:EGFP;Cd4-1:mCherry) control zebrafish at 7 days post-fertilization (dpf). EGFP-positive neural crest-derived cells are shown in green, and CD4+ cells are shown in red. Few CD4+ cells are observed within or surrounding the dβh-expressing region at this developmental stage. Please click here to download this file.

Supplementary Video 2. Representative confocal z-stack of a MYCN-expressing zebrafish at 7 days post-fertilization. Three-dimensional confocal imaging of a Tg(dβh:MYCN;dβh:EGFP;Cd4-1:mCherry) zebrafish at 7 days post-fertilization (dpf). EGFP-positive MYCN-expressing premalignant neuroblastoma cells are shown in green, and CD4+ cells are shown in red. Similar to control fish, few CD4+ cells are observed within or surrounding the tumor region at this early developmental stage. Please click here to download this file.

Supplementary Video 3. Representative confocal z-stack of a control zebrafish at 14 days post-fertilization. Three-dimensional confocal imaging of a Tg(dβh:EGFP;Cd4-1:mCherry) control zebrafish at 14 days post-fertilization (dpf). EGFP-positive neural crest-derived cells are shown in green, and CD4+ cells are shown in red. CD4+ cells are sparsely distributed and show limited association with the dβh-expressing region. Please click here to download this file.

Supplementary Video 4. Representative confocal z-stack of a MYCN-expressing zebrafish at 14 days post-fertilization. Three-dimensional confocal imaging of a Tg(dβh:MYCN;dβh:EGFP;Cd4-1:mCherry) zebrafish at 14 days post-fertilization (dpf). EGFP-positive MYCN-expressing premalignant neuroblastoma cells are shown in green, and CD4+ cells are shown in red. Increased accumulation and infiltration of CD4+ cells are observed in association with the enlarged tumor region compared with age-matched control fish, consistent with the quantification shown in Figure 2B. Please click here to download this file.

Discussion

The protocol described here utilizes zebrafish as an in vivo model to visualize and quantify immune cells within the TME. Several factors are critical for successful implementation of this approach. First, appropriate selection and validation of compound transgenic zebrafish lines are essential. Larvae should be screened for the expected fluorescent expression patterns and, if required, confirmed by genotyping. Immune-reporter and oncogene expression should be verified prior to experimentation to ensure accurate assignment of experimental and control groups. Second, accurate identification of the region of interest is critical during confocal imaging. Bright-field imaging can be used to identify anatomical landmarks and facilitate localization of the target tissue. For example, when imaging tumors in the anterior body region, the eye may be used as a landmark to aid localization. Third, proper positioning of the fish is essential to ensure adequate exposure of the imaging region. Improper alignment may reduce image quality or obscure the tissue of interest. Finally, appropriate mounting and immobilization are required to minimize motion artifacts during live imaging. Tricaine concentration and imaging duration should be optimized to maintain larval viability while preserving image quality.

Phototoxicity can be minimized by reducing laser intensity and exposure time during live imaging. For adult samples, tissues should be maintained on ice during handling and imaging preparation because repeated thawing may alter tissue integrity. Careful sample handling is particularly important following cryosectioning and removal from the OCT block.

Interpretation of imaging results requires consideration of reporter specificity. Several immune-reporter lines label multiple immune cell populations. For example, CD4 expression has been reported in cell populations beyond conventional T cells, including macrophages28. In addition, besides macrophages, mpeg expression is also detected in B cells29. Lysc can label both neutrophils and macrophages30. Consequently, fluorescent reporter expression alone may not be sufficient to definitively assign cell identity. Additional validation approaches, such as RNAscope, flow cytometry, quantitative reverse-transcription polymerase chain reaction, or single-cell RNA sequencing, may complement imaging-based observations and provide additional molecular characterization of the labeled cell populations.

This method has several limitations. The approach relies on fluorescent reporter expression and therefore cannot independently confirm immune cell identity or functional state. In addition, image analysis in the present workflow for adult fish is based on projected confocal datasets of limited layers and may not fully capture complex three-dimensional cellular relationships within the TME. Finally, the method also requires generation and maintenance of compound transgenic zebrafish lines, which may limit accessibility for some laboratories.

Despite these limitations, the protocol provides a practical approach for visualizing immune cells associated with neuroblastoma lesions in zebrafish. Compared with conventional endpoint histology, the method preserves tissue architecture and enables imaging of fluorescently labeled cells within intact tissues20,21. The workflow can be applied across multiple developmental stages and can be adapted to additional fluorescent reporter lines. Beside neuroblastoma, multiple studies have imaged the TME for the interaction between melanoma and immune cells, including CD4+ cells, macrophages, and CD8+ cells15,21,31,32. Together, these features make the protocol a useful platform for studying immune cell localization within the zebrafish TME.

Disclosures

The authors declare no competing interests.

Acknowledgements

We acknowledge support from the National Institutes of Health (NIH; 1UL1TR001430, CA215059, and NS140967), the American Cancer Society (RSG-17-204-01-TBG), the National Science Foundation (1911253), and Alex’s Lemonade Stand Foundation to H.F.; and from a Warren Alpert Distinguished Scholars Fellowship to X.Q. Y.W. was supported by the Boston University Undergraduate Research Opportunities Program (UROP) and the St. Baldrick’s Summer Fellowship Program. M.V. was supported by the St. Baldrick’s Summer Fellowship Program. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
200 µL Gel Loading TipMilliporeSigma1022-0600Used for larval manipulation
Artificial PlantsThe Hidden Reef62874200000000000Optional breeding enrichment
BleachFisher Scientific50371500Used for embryo decontamination
Cell Counter PluginNational Institutes of Health (NIH)N/AFiji plugin used for cell quantification
Computer and MonitorHP2TB68A8#ABAUsed for image acquisition and analysis
Confocal MicroscopeZeissLSM 710Used for larval and adult imaging
Cryomold, PlasticEpredia22-050-160Used for OCT embedding
CryostatThermo Fisher Scientific95-664-0EC70Used for cryosectioning
Dry IceFisher ScientificN/AUsed for sample transport
Fiji SoftwareNational Institutes of Health (NIH)Version 1.54pImage analysis software
Fine-Mesh NetCarolina Biological651345Used for embryo collection
Fish IncubatorVWR35960-056Maintained at 28.5°C
ForcepsFisher Scientific10-316BUsed for sample handling
Glass-Bottom DishIBIDI81218-200Used for imaging
Low-Melting AgaroseProlab Supply9012-36-6Used for larval and adult mounting
Mating Tank (main tank, divider, grated section)Carolina Biological161937Used for zebrafish breeding
Nutating RockerMidsciR2D-30Used for fixation during overnight incubation
OCT CompoundTissue-Tek4583Embedding medium for cryosectioning
Paraformaldehyde (PFA)Sigma Aldrich158127-500GFixative
Petri Dish, PlasticMilliporeSigmaBR452000Used for embryo and larval handling
Phosphate-Buffered Saline (PBS)Gibco14080-055Used for washing and fixation procedures
Plastic Transfer PipetteFisher Scientific50-998-100Used for embryo and larval transfer
Razor BladeFisher Scientific12-640Used during sample preparation
Conductivity MeterYSIEC300ACC-04Used to verify rotifer water salinity
RotifersThe Hidden Reef116151603Used for larval rearing
Sodium ThiosulfateThermo Fisher ScientificAAA1762936Used for bleach neutralization
SucroseFisher ScientificS25590ACryoprotection reagent
Tricaine MethanesulfonateWestern ChemicalNC0872873Anesthetic; sold by Fisher Scientific
TweezersFisher Scientific12-000-122Used for sample handling
Upright Fluorescence MicroscopeLeicaM165Used for fluorescence screening

References

  1. Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921-R925.
  2. Kumagai S, Momoi Y, Nishikawa H. Immunogenomic cancer evolution: A framework to understand cancer immunosuppression. Sci Immunol. 2025;10(105):eabo5570.
  3. Keren L, et al. A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging. Cell. 2018;174(6):1373-1387.e19.
  4. Gerner MY, et al. Histo-cytometry: A method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes. Immunity. 2012;37(2):364-376.
  5. Pittet MJ, Weissleder R. Intravital imaging. Cell. 2011;147(5):983-991.
  6. Wienke J, et al. The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology. Eur J Cancer. 2021;144:123-150.
  7. Spitzer MH, Nolan GP. Mass cytometry: Single cells, many features. Cell. 2016;165(4):780-791.
  8. Roy D, et al. Zebrafish—A suitable model for rapid translation of effective therapies for pediatric cancers. Cancers (Basel). 2024;16(7):1361.
  9. White RM, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell. 2008;2(2):183-189.
  10. MacRae CA, Peterson RT. Zebrafish as tools for drug discovery. Nat Rev Drug Discov. 2015;14(10):721-731.
  11. Miao KZ, et al. Tipping the scales with zebrafish to understand adaptive tumor immunity. Front Cell Dev Biol. 2021;9:660969.
  12. Povoa V, et al. Innate immune evasion revealed in a colorectal zebrafish xenograft model. Nat Commun. 2021;12(1):1156.
  13. Wang J, et al. Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development. Cancer Res. 2015;75(2):306-315.
  14. Loveless R, Shay C, Teng Y. Unveiling tumor microenvironment interactions using zebrafish models. Front Mol Biosci. 2020;7:611847.
  15. Dee CT, et al. CD4-transgenic zebrafish reveal tissue-resident Th2- and regulatory T cell-like populations and diverse mononuclear phagocytes. J Immunol. 2016;197(9):3520-3530.
  16. Murali Shankar N, et al. Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer. Front Immunol. 2023;14:1254821.
  17. Tan KE, et al. LMO1 expression in neuroblastoma cells reprograms tumor-associated macrophages to promote metastasis. iScience. 2026;29(3):115144.
  18. Fior R, et al. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc Natl Acad Sci U S A. 2017;114(39):E8234-E8243.
  19. Fazio M, et al. Zebrafish patient avatars in cancer biology and precision cancer therapy. Nat Rev Cancer. 2020;20(5):263-273.
  20. Qin X, et al. CKLF instigates a “cold” microenvironment to promote MYCN-mediated tumor aggressiveness. Sci Adv. 2024;10(11):eadh9547.
  21. Ludin A, et al. CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success. Cell. 2025;188(24):6720-6736.e26.
  22. Zhu S, et al. LMO1 synergizes with MYCN to promote neuroblastoma initiation and metastasis. Cancer Cell. 2017;32(3):310-323.e5.
  23. Tao T, et al. The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma. Oncogene. 2017;36(27):3852-3867.
  24. Zimmerman MW, et al. MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification. Cancer Discov. 2018;8(3):320-335.
  25. Dankert EN, Look AT, Zhu S. Unraveling neuroblastoma pathogenesis with the zebrafish. Cell Cycle. 2018;17(4):395-396.
  26. Langenau DM, et al. In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc Natl Acad Sci U S A. 2004;101(19):7369-7374.
  27. Lam SH, et al. Development and maturation of the immune system in zebrafish, Danio rerio: A gene expression profiling, in situ hybridization and immunological study. Dev Comp Immunol. 2004;28(1):9-28.
  28. Zhen A, et al. CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection. J Virol. 2014;88(17):9934-9946.
  29. Ferrero G, et al. The macrophage-expressed gene (mpeg)1 identifies a subpopulation of B cells in the adult zebrafish. J Leukoc Biol. 2020;107(3):431-443.
  30. Hall C, et al. The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish. BMC Dev Biol. 2007;7:42.
  31. Lorenzini F, et al. Melanoma innervation, noradrenaline and cancer progression in zebrafish xenograft model. Cell Death Discov. 2025;11(1):260.
  32. Ramakrishnan G, et al. Real-time imaging reveals a role for macrophage protrusive motility in melanoma invasion. J Cell Biol. 2025;224(2):e202403096.

Reprints and Permissions

Tags

Immune Cell ImagingNeuroblastoma CellsImmune Cell QuantificationTransgenic ZebrafishFluorescent LabelingIn Vivo ImagingImmune Tumor InteractionsCD4 Positive Cells

This article has been published

Video Coming Soon